Table 3.
MADRS scores from post-infusion days 1 to 3 | ||||
---|---|---|---|---|
Coefficient | 95% CI | t-value | p-value | |
Intercept | 16.6 | 11.3 to 21.9 | 6.15 | <0.001 |
Group | −5.82 | −13.3 to 1.64 | −1.53 | 0.13 |
Time | 0.24 | −2.04 to 2.52 | 0.21 | 0.84 |
Group×Time | 1.70 | −1.54 to 4.93 | 1.03 | 0.30 |
Change from pre-infusion baseline MADRS scores on post-infusion days 1 to 3 | ||||
Coefficient | 95% CI | t-value | p-value | |
Intercept | −15.0 | −20.1 to −9.95 | −5.79 | <0.001 |
Group | 0.82 | −6.25 to 7.89 | 0.23 | 0.82 |
Time | 0.58 | −1.77 to 2.93 | 0.49 | 0.63 |
Group×Time | 1.33 | −1.96 to 4.62 | 0.79 | 0.43 |
MADRS, Montgomery–Åsberg Depression Rating Scale. CI, confidence interval. The effect of group on MADRS scores from post-infusion days 1 to 3 was not significant (p=0.13 using absolute scores and p=0.82 using change from baseline scores). Significance was evaluated using likelihood ratio tests and applying the normal approximation to Wald t values from the model output. No adjustments for multiple comparisons were made for the two models presented here.